newsfilter
← Latest News
Business Wire·

Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

$4.2 million total revenue for the full year 2021 2021 highlights include Current Procedural Terminology (CPT) codes for prescribers, first state Medicaid coverage decision, two major PBM formulary additions, more than 30 organizations providin